Pfizer Ventures (US) LLC 4
4 · SpringWorks Therapeutics, Inc. · Filed Sep 19, 2019
Insider Transaction Report
Form 4
PFIZER INC
10% Owner
Transactions
- Conversion
Junior Series A Convertible Preferred Stock
2019-09-17−6,437,500→ 0 total→ Common Stock (978,194 underlying) - Conversion
Common Stock
2019-09-17+526,602→ 4,543,847 total - Conversion
Series A Convertible Preferred Stock
2019-09-17−20,000,000→ 0 total→ Common Stock (3,039,051 underlying) - Conversion
Common Stock
2019-09-17+978,194→ 978,194 total - Conversion
Common Stock
2019-09-17+3,039,051→ 4,017,245 total - Purchase
Common Stock
2019-09-17$18.00/sh+50,000$900,000→ 4,593,847 total - Conversion
Series B Convertible Preferred Stock
2019-09-17−3,465,571→ 0 total→ Common Stock (526,602 underlying)
Footnotes (5)
- [F1]Each share of Junior Series A Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 6.5810:1 basis upon the closing of the Issuer's initial public offering for no additional consideration. The Junior Series A Convertible Preferred Stock had no expiration date. Such shares are held of record by Pfizer Inc. ("Pfizer").
- [F2]Each share of Series A Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 6.5810:1 basis upon the closing of the Issuer's initial public offering for no additional consideration. The Series A Convertible Preferred Stock had no expiration date. Such shares are held of record by Pfizer.
- [F3]Each share of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 6.5810:1 basis upon the closing of the Issuer's initial public offering for no additional consideration. The Series B Convertible Preferred Stock had no expiration date. Such shares are held of record by Pfizer Ventures (US) LLC, a wholly-owned subsidiary of Pfizer ("PVUS").
- [F4]PVUS purchased such additional shares of Common Stock in the Issuer's initial public offering at the initial public offering price of $18.00 per share.
- [F5]Each Reporting Person disclaims ownership of securities held by the other Reporting Person, except to the extent of its pecuniary interest therein.